Greenrise Global’s Supports Germany’s Approach 
to Cannabis Legalization for Adult Use

BERLIN, ERFURT, Germany – November 25th, 2021, Greenrise Global Brands Inc. (formerly AMP Alternative Medical Products Inc.) (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX) (“Greenrise Global”) would like to comment on…

Continue ReadingGreenrise Global’s Supports Germany’s Approach 
to Cannabis Legalization for Adult Use

Greenrise Global Launches Herbify CBD Wellness Brand in Germany

BERLIN, HAMBURG, Germany – November 23rd, 2021, Greenrise Global Brands Inc.’s (formerly AMP Alternative Medical Products Inc.) (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX), (“Greenrise Global”), announces the launch of its…

Continue ReadingGreenrise Global Launches Herbify CBD Wellness Brand in Germany

Greenrise Global Announces Non-Brokered Placement Offering of Units

BERLIN, Germany – November 22nd, 2021, Greenrise Global Brands Inc.’s (formerly AMP Alternative Medical Products Inc.) (Frankfurt: C4T, ISIN: CA39540L1085) (CSE: XCX), (“Greenrise Global”), announces it intend to raise up…

Continue ReadingGreenrise Global Announces Non-Brokered Placement Offering of Units

AMP Announces Strategic Acquisition of German CBD Wellness 
Company and Leading Cannabis Executive Team

BERLIN, Germany – November 3rd, 2021, AMP Alternative Medical Products Inc. (Frankfurt: C4TA, ISIN: CA0318961038) (CSE: XCX), (the “Company”) announces it has acquired Greenrise GmbH (“Greenrise Wellbeing”) from its founders,…

Continue ReadingAMP Announces Strategic Acquisition of German CBD Wellness 
Company and Leading Cannabis Executive Team

AMP Becomes Exclusive Marketing Partner of Tilray for Aphria Medical Cannabis Brand in Germany

ERFURT and BERLIN, Germany – September 28th, 2021, AMP Alternative Medical Products Inc. (Frankfurt: C4TA, ISIN: CA0318961038) (CSE: XCX) (“AMP”), a pharmaceutical supplier of medical and CBD therapeutic wellness cannabis…

Continue ReadingAMP Becomes Exclusive Marketing Partner of Tilray for Aphria Medical Cannabis Brand in Germany

AMP and Waldhausklinik Deuringen Announce Clinical Study into the Effects of Medical Cannabis

ERFURT / BERLIN and STADTBERGEN, Germany – September 13th, 2021, AMP Alternative Medical Products Inc. (Frankfurt: C4TA, ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis products to German…

Continue ReadingAMP and Waldhausklinik Deuringen Announce Clinical Study into the Effects of Medical Cannabis

AMP Launches its CBD Brand, CANAVEX® at YES!CON, Germany’s Largest Cancer Convention

ERFURT / BERLIN, Germany – September 8th, 2021, AMP Alternative Medical Products Inc. (Frankfurt: C4TA, ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of cosmetic CBD cannabis products to German pharmacies,…

Continue ReadingAMP Launches its CBD Brand, CANAVEX® at YES!CON, Germany’s Largest Cancer Convention

AMP Appoints National Sales Director and Launches Nationwide Marketing Sales Campaign for Branded Medical Cannabis Products in Germany

ERFURT and BERLIN, Germany, April 7th, 2021, AMP Alternative Medical Products Inc. (Frankfurt: C4TA, ISIN: CA0318961038) (CSE: XCX), a pharmaceutical supplier of medical cannabis to German pharmacies, announces the appointment…

Continue ReadingAMP Appoints National Sales Director and Launches Nationwide Marketing Sales Campaign for Branded Medical Cannabis Products in Germany